NCT01076491View on ClinicalTrials.gov

High Dose Inhaled Mannitol Study

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

March 31, 2009

Study Completion Date

April 30, 2009

Conditions

Bronchiectasis

Interventions

DRUG

mannitol

inhaled mannitol - single doses of either 70 mg or 90 mg

Trial Locations (1)

2050

Royal Prince Alfred Hospital, Sydney

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Syntara

INDUSTRY